Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 3Terminated 1Recruiting 1

Sponsor Class

OTHER 9OTHER_GOV 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 431Breast Neoplasms 300Neoplasms 297Colorectal Neoplasms 245Neoplasm Metastasis 193Ovarian Neoplasms 173Lung Neoplasms 151Prostatic Neoplasms 149Recurrence 147Pancreatic Neoplasms 143Multiple Myeloma 134Stomach Neoplasms 130Squamous Cell Carcinoma of Head and Neck 128Melanoma 123Endometrial Neoplasms 119Leukemia, Myeloid, Acute 114Advanced Solid Tumors 113Advanced Solid Tumor 111Triple Negative Breast Neoplasms 103Carcinoma, Hepatocellular 102Uterine Cervical Neoplasms 90Small Cell Lung Carcinoma 88Lymphoma, Non-Hodgkin 84Carcinoma, Renal Cell 72Lymphoma, Follicular 71Lymphoma 69Leukemia, Lymphocytic, Chronic, B-Cell 65Solid Tumor 64Lymphoma, Large B-Cell, Diffuse 64Esophageal Neoplasms 61

Interventions

Tadalafil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × INDUSTRY × Erectile Dysfunction × Clear all
NCT05558007 2024-10-22

Safety and Efficacy Evaluation of BZ371A Topically Applied on Prostatectomized Patients

Biozeus Biopharmaceutical S.A.

Phase 2 Recruiting
72 enrolled
Genitourinary

Erectile Dysfunction, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡